This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Dec;16(16):e586.

doi: 10.1016/S1470-2045(15)00368-X.

Survival of patients with metastatic breast cancer with or without locoregional therapy

Kazunori Honda¹, Bishal Gyawali², Yuichi Ando²

Affiliations

Affiliations

¹ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan. Electronic address: kh99081@med.nagoya-u.ac.jp.
² Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan.

PMID: 26678206
DOI: 10.1016/S1470-2045(15)00368-X

Comment

Survival of patients with metastatic breast cancer with or without locoregional therapy

Kazunori Honda et al. Lancet Oncol. 2015 Dec.

. 2015 Dec;16(16):e586.

doi: 10.1016/S1470-2045(15)00368-X.

Authors

Kazunori Honda¹, Bishal Gyawali², Yuichi Ando²

Affiliations

¹ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan. Electronic address: kh99081@med.nagoya-u.ac.jp.
² Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan.

PMID: 26678206
DOI: 10.1016/S1470-2045(15)00368-X

No abstract available

PubMed Disclaimer

Comment in

Survival of patients with metastatic breast cancer with or without locoregional therapy - Authors' reply.
Badwe R, Gupta S, Nair N, Parmar V, Hawaldar R. Badwe R, et al. Lancet Oncol. 2015 Dec;16(16):e587-8. doi: 10.1016/S1470-2045(15)00479-9. Lancet Oncol. 2015. PMID: 26678208 No abstract available.

Comment on

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S. Badwe R, et al. Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9. Lancet Oncol. 2015. PMID: 26363985 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information